Drugs / Technosphere Insulin Inhalation Powder
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01544881 | Mar → Sep 2012 | type 1 diabetes mellitus | Mannkind Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Technosphere Insulin Inhalation Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01544881 ↗ |
| Route | Inhaled | “one dose of TI inhaled using the Gen2C device” NCT01544881 ↗ |